Welcome to our dedicated page for Enovis SEC filings (Ticker: ENOV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enovis Corporation filings document the formal disclosures of a public medical technology company with Reconstructive and Prevention & Recovery operations. Recent Form 8-K reports cover quarterly and annual results, furnished earnings releases, conference presentation materials and Regulation FD disclosures tied to management presentations.
The filing record also includes proxy materials for annual meeting governance, board and executive compensation matters, executive transition disclosures, and material financing agreements. Enovis filings describe credit facilities, leverage covenants, guarantor arrangements, senior unsecured convertible notes references, financial condition, segment performance and related risk and governance subjects.
Enovis Corp Chief Administrative Officer Oliver Engert bought a total of 1,750 shares of common stock in open-market transactions. He purchased 250 shares and 500 shares on March 6, 2026 at prices of $24.28 and $24.48 per share, and 1,000 shares on March 9, 2026 at $23.39 per share. Following these purchases, he directly owns 46,640 shares of Enovis common stock.
Enovis CORP senior executive reports tax-related share disposition
Enovis CORP SVP and Chief Legal Officer Bradley J. Tandy reported a Form 4 transaction involving 1,102 shares of common stock on March 4, 2026. The shares were withheld by the company at a price of $25.79 per share to cover tax withholding obligations tied to the net settlement of restricted stock units.
The footnote clarifies this was a tax-withholding disposition and not an open-market sale by the executive. After this transaction, Tandy directly owned 41,929 shares of Enovis common stock.
Enovis CORP executive reports tax-related share withholding. Group President, P&R Terry D. Ross reported a disposition of 765 shares of Enovis common stock on March 4, 2026 at $25.79 per share. These shares were withheld by the company to cover tax obligations from the net settlement of restricted stock units and are explicitly described as not representing a sale by the reporting person. After this withholding, Ross directly owns 34,606 shares of Enovis common stock.
Enovis Corp principal accounting officer John Kleckner reported a small tax-related share disposition. On the reported date, 442 shares of Enovis common stock at $25.79 per share were withheld by the company to cover tax obligations tied to the net settlement of restricted stock units, which the footnote states does not represent a sale by Kleckner. After this withholding, he held 11,545 shares directly.
Enovis CORP director Shirley Brady reported a tax-related share disposition. On March 4, 2026, 3,059 shares of Enovis common stock at $25.79 per share were withheld by the company to satisfy tax withholding obligations tied to restricted stock units.
The footnote explains this was not an open-market sale by Brady but a tax-withholding disposition in connection with net settlement of RSUs. After this transaction, Brady directly owned 101,243 Enovis shares.
Enovis CORP’s Senior Vice President and Chief Financial Officer Phillip Benjamin (Ben) Berry reported an automatic share disposition tied to equity compensation. On the Form 4, 2,220 shares of common stock at $25.79 per share were withheld by the company to satisfy tax withholding obligations upon net settlement of restricted stock units, as clarified in the footnote that this does not represent a sale by the reporting person. After this tax-withholding event, Berry’s directly held common stock position is 113,789 shares.
Enovis Corp executive Louis Vogt, Group President, Recon, reported a Form 4 transaction involving company common stock. On March 4, 2026, 888 shares were withheld by the company at $25.79 per share to cover tax obligations from the net settlement of restricted stock units. The footnote explains this was a tax-withholding event and not an open-market sale by Vogt. After this withholding, Vogt directly owned 34,608 shares of Enovis common stock.
Enovis CORP senior vice president and chief HR officer Patricia A. Lang reported a tax-related share disposition through net settlement of restricted stock units. The company withheld 1,173 shares of common stock at $25.79 per share to cover tax withholding and remittance obligations, and the filing states this does not represent a sale by Lang. After this withholding, she directly holds 53,086 shares of Enovis common stock.
Enovis CORP Chief Administrative Officer Oliver Engert reported buying 1,250 shares of common stock in open-market transactions. He purchased 1,000 shares at a weighted average price of $24.77 on March 3, 2026, and 250 shares at $25.10 on March 4, 2026, bringing his direct holdings to 44,890 shares.
The filing notes that the $24.77 price reflects a weighted average for multiple trades completed between $24.64 and $24.89 per share.
Enovis CORP senior executive reports routine tax-share withholding. SVP and Chief Legal Officer Bradley J. Tandy had 484 shares of common stock, at a price of $25.47 per share, withheld by the company to cover tax obligations from restricted stock units. After this non‑market tax-withholding disposition, he holds 43,031 shares directly.